CMT Research Foundation Invests in XtRNA Bio to Develop Gene Therapy for CMT2D
ATLANTA, GA, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- CMT Research Foundation has invested in a research project with XtRNA Bio aimed to develop a new viral gene therapy for Charcot-Marie-Tooth disease type 2D. CMT2D is caused by …